These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 10388256)
1. Pulmonary sarcoidosis: comparison of patients at a university and a municipal hospital. Yeager H; Rabin DL; Stein SR; Richardson MS; Singh R; Devine MA; Freedman M J Natl Med Assoc; 1999 Jun; 91(6):322-7. PubMed ID: 10388256 [TBL] [Abstract][Full Text] [Related]
2. Are sociodemographic factors important in sarcoidosis? Young RC J Natl Med Assoc; 1999 Jun; 91(6):327-8. PubMed ID: 10388257 [No Abstract] [Full Text] [Related]
4. Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort. Benn BS; Lehman Z; Kidd SA; Ho M; Sun S; Ramstein J; Arger NK; Nguyen CP; Su R; Gomez A; Gelfand JM; Koth LL Lung; 2017 Oct; 195(5):553-561. PubMed ID: 28707108 [TBL] [Abstract][Full Text] [Related]
5. A new tool to assess sarcoidosis severity. Wasfi YS; Rose CS; Murphy JR; Silveira LJ; Grutters JC; Inoue Y; Judson MA; Maier LA Chest; 2006 May; 129(5):1234-45. PubMed ID: 16685014 [TBL] [Abstract][Full Text] [Related]
6. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Judson MA; Boan AD; Lackland DT Sarcoidosis Vasc Diffuse Lung Dis; 2012 Oct; 29(2):119-27. PubMed ID: 23461074 [TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis. Keijsers RG; Verzijlbergen EJ; van den Bosch JM; Zanen P; van de Garde EM; Oyen WJ; Grutters JC Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):123-9. PubMed ID: 22117503 [TBL] [Abstract][Full Text] [Related]
8. Optimal scoring of serial change on chest radiography in sarcoidosis. Zappala CJ; Desai SR; Copley SJ; Spagnolo R; Cramer D; Sen D; Alam SM; du Bois RM; Hansell DM; Wells AU Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):130-8. PubMed ID: 22117504 [TBL] [Abstract][Full Text] [Related]
9. Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange. Lamberto C; Nunes H; Le Toumelin P; Duperron F; Valeyre D; Clerici C Chest; 2004 Jun; 125(6):2061-8. PubMed ID: 15189922 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of infliximab on refractory sarcoidosis. Ørum M; Hilberg O; Krag S; Bendstrup E Dan Med J; 2012 Dec; 59(12):A4535. PubMed ID: 23290282 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of Lung Function Phenotypes in Sarcoidosis: Role of Race and Sex Differences. Sharp M; Psoter KJ; Balasubramanian A; Pulapaka AV; Chen ES; Brown SW; Mathai SC; Gilotra NA; Chrispin J; Bascom R; Bernstein R; Eakin MN; Wise RA; Moller DR; McCormack MC Ann Am Thorac Soc; 2023 Jan; 20(1):30-37. PubMed ID: 35926103 [No Abstract] [Full Text] [Related]
12. Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients? Marcellis RG; Lenssen AF; de Vries GJ; Baughman RP; van der Grinten CP; Verschakelen JA; De Vries J; Drent M Lung; 2013 Feb; 191(1):43-52. PubMed ID: 23138855 [TBL] [Abstract][Full Text] [Related]
14. Estimation using the impulse oscillation system in patients with pulmonary sarcoidosis. Suzuki T; Tsushima K; Kawata N; Matsumura T; Matsuura Y; Ichimura Y; Terada J; Sakao S; Tada Y; Tanabe N; Tatsumi K Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):144-50. PubMed ID: 26278694 [TBL] [Abstract][Full Text] [Related]
15. Spirometry, cardiopulmonary exercise testing and the six-minute walk test results in sarcoidosis patients. Kiani A; Eslaminejad A; Shafeipour M; Razavi F; Seyyedi SR; Sharif-Kashani B; Emami H; Bakhshayesh-Karam M; Abedini A Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):185-194. PubMed ID: 32476953 [TBL] [Abstract][Full Text] [Related]
16. Racial difference in sarcoidosis mortality in the United States. Mirsaeidi M; Machado RF; Schraufnagel D; Sweiss NJ; Baughman RP Chest; 2015 Feb; 147(2):438-449. PubMed ID: 25188873 [TBL] [Abstract][Full Text] [Related]
17. Clinical features and outcomes of asymptomatic pulmonary sarcoidosis. A comparative cohort study. Iriarte A; Rubio-Rivas M; Villalba N; Corbella X; Mañá J Respir Med; 2020 Aug; 169():105998. PubMed ID: 32442109 [TBL] [Abstract][Full Text] [Related]
18. Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis. Baydur A; Alsalek M; Louie SG; Sharma OP Chest; 2001 Jul; 120(1):102-8. PubMed ID: 11451823 [TBL] [Abstract][Full Text] [Related]
19. Mixed Ventilatory Defects in Pulmonary Sarcoidosis: Prevalence and Clinical Features. Kouranos V; Ward S; Kokosi MA; Castillo D; Chua F; Judge EP; Thomas S; Van Tonder F; Devaraj A; Nicholson AG; Maher TM; Renzoni EA; Wells AU Chest; 2020 Nov; 158(5):2007-2014. PubMed ID: 32534908 [TBL] [Abstract][Full Text] [Related]
20. Circulating D dimer in patients with sarcoidosis. Shorr AF; Hnatiuk OW Chest; 2000 Apr; 117(4):1012-6. PubMed ID: 10767232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]